Requirement for lymphocytes and resident macrophages in LPS‐induced pleural eosinophil accumulation

In this study we investigated the involvement of inflammatory cells in the pleural accumulation of eosinophils induced by lipopolysaccharide (LPS). Intrathoracic (i.t.) injection of LPS (250 ng/cavity) into rats induced a significant eosinophil accumulation that developed within 24 h, was maximal at 48 h, and returned to control values within 120 h. This eosinophil influx was preceded by a huge neutrophil influx within 4 h and accompanied by a mononuclear cell accumulation between 24 and 48 h. Pretreatment with an antineutrophil monoclonal antibody (RP‐3, 2 ml per animal) selectively reduced the number of circulating neutrophils within 8 h but failed to alter the LPS‐induced eosinophilia. Similarly, platelet depletion with an anti‐rat platelet antiserum did not alter the LPS‐induced eosinophil accumulation. Cyclosporine (50 mg/kg, 12 and 2 h before) partially inhibited (51%) the LPS‐induced pleural eosinophilia, whereas the eosinophilia was not changed by prior degranulation of pleural mast cells with polymyxin B (10 μg/cavity, 24 h before). Moreover, selective depletion of T lymphocytes using an anti‐Thy 1.0 monoclonal antibody significantly inhibited the eosinophilia triggered by LPS. The i.t. injection of liposomes containing dichloromethylene diphosphonate significantly reduced (65%) the number of resident macrophages after 5 days. Under this condition, the eosinophil infiltration induced by LPS was completely inhibited. Accordingly, the i.t. injection of supernatant from macrophage monolayers, obtained from the pleural cavities of LPS‐injected rats, into naive recipient animals led to a twofold increase in the number of pleural eosinophils. In conclusion, our data suggest an important role for resident macrophages and T lymphocytes in the eosinophil accumulation induced by LPS. J. Leukoc. Biol. 56: 151–158; 1994.

[1]  M. Martins,et al.  Lipopolysaccharide-induced pleural neutrophil accumulation depends on marrow neutrophils and platelet-activating factor. , 1994, European journal of pharmacology.

[2]  M. Martins,et al.  IL-5 accounts for the mouse pleural eosinophil accumulation triggered by antigen but not by LPS. , 1994, Immunopharmacology.

[3]  M. Martins,et al.  Pharmacological modulation of lipopolysaccharide-induced pleural eosinophilia in the rat; a role for a newly generated protein. , 1993, European journal of pharmacology.

[4]  L. Faccioli,et al.  Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo. , 1993, Immunology.

[5]  A. Reder,et al.  T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis. , 1993, Cellular immunology.

[6]  M. Vieytes,et al.  Rat pleural and peritoneal mast cells stimulated at different cellular levels: difference in and influence of purification media. , 1993, International archives of allergy and immunology.

[7]  K. Takatsu,et al.  Role of CD4+ T lymphocytes and interleukin‐5 in antigen‐induced eosinophil recruitment into the site of cutaneous late‐phase reaction in mice , 1992, Journal of leukocyte biology.

[8]  K. Takatsu,et al.  CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. , 1992, The American review of respiratory disease.

[9]  A. Mallet,et al.  Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils , 1992, The Journal of experimental medicine.

[10]  Y. Hitoshi,et al.  Role of interleukin-5 in local accumulation of eosinophils in mouse allergic peritonitis. , 1991, International archives of allergy and applied immunology.

[11]  M. Martins,et al.  Endotoxin induces eosinophil accumulation in the rat pleural cavity. , 1991, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[12]  R. Borojevic,et al.  Eosinophil granulocyte proliferation and differentiation in schistosomal granulomas are controlled by two cytokines. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[13]  T. Standiford,et al.  Human neutrophils exhibit disparate chemotactic factor gene expression. , 1990, Biochemical and biophysical research communications.

[14]  B. Uitdehaag,et al.  Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages , 1990, The Journal of experimental medicine.

[15]  F. Padova,et al.  Pharmacology of cyclosporine (sandimmune). V. Pharmacological effects on immune function: in vitro studies. , 1990, Pharmacological reviews.

[16]  J. Borel Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo. , 1990, Pharmacological reviews.

[17]  K. Glaser,et al.  Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. , 1990, The Journal of clinical investigation.

[18]  C. Sanderson Eosinophils. A Comprehensive Review and Guide to the Scientific and Medical Literature , 1989 .

[19]  T. Watanabe,et al.  Selective Depletion of Rat Neutrophils by In Vivo Administration of a Monoclonal Antibody , 1989, Journal of leukocyte biology.

[20]  R. Strieter,et al.  Interleukin-2-induced tumor necrosis factor-alpha (TNF-alpha) gene expression in human alveolar macrophages and blood monocytes. , 1989, The American review of respiratory disease.

[21]  M. Cybulsky,et al.  Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[22]  J. David,et al.  Characterization of a factor from the U937 cell line that enhances the toxicity of human eosinophils to Schistosoma mansoni larvae. , 1987, Journal of Immunology.

[23]  D. Goeddel,et al.  Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta. , 1985, Journal of immunology.

[24]  B. Czarnetzki,et al.  In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and its w-oxidation products. , 1985, Prostaglandins.

[25]  W. Fiers,et al.  Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes. , 1985, Journal of immunology.

[26]  H. Movat,et al.  Kinetics of neutrophil accumulation in acute inflammatory lesions induced by chemotaxins and chemotaxinigens. , 1984, Journal of immunology.

[27]  H. Movat,et al.  The in vivo quantitation and kinetics of monocyte migration into acute inflammatory tissue. , 1981, The American journal of pathology.

[28]  H. Movat,et al.  Kinetics of acute inflammation induced by E coli in rabbits. Quantitation of blood flow, enhanced vascular permeability, hemorrhage, and leukocyte accumulation. , 1980, The American journal of pathology.

[29]  M Tuszkiewicz,et al.  [Bacterial endotoxins]. , 1967, Polski tygodnik lekarski.